Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
admin 22nd August 2018 Uncategorised 0Novartis has been battling claims it illegally protected the market for blockbuster cancer drug Gleevec, but this week the drugmaker prevailed against the cases in appeals.
More: Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
Source: fierce